206 related articles for article (PubMed ID: 9417860)
21. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
[TBL] [Abstract][Full Text] [Related]
22. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
[TBL] [Abstract][Full Text] [Related]
23. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
24. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.
Arcellana-Panlilio MY; Egeler RM; Ujack E; Magliocco A; Stuart GC; Robbins SM; Coppes MJ
Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer.
Lee M; Sup Han W; Kyoung Kim O; Hee Sung S; Sun Cho M; Lee SN; Koo H
Pathol Res Pract; 2006; 202(6):415-24. PubMed ID: 16675157
[TBL] [Abstract][Full Text] [Related]
26. The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression.
Ohtani N; Yamakoshi K; Takahashi A; Hara E
J Med Invest; 2004 Aug; 51(3-4):146-53. PubMed ID: 15460900
[TBL] [Abstract][Full Text] [Related]
27. [Tumor suppressor RB gene and its related molecules in hepatocellular carcinoma].
Nishida N; Fukuda Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():134-7. PubMed ID: 11761929
[No Abstract] [Full Text] [Related]
28. Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information.
Ruas M; Brookes S; McDonald NQ; Peters G
Oncogene; 1999 Sep; 18(39):5423-34. PubMed ID: 10498896
[TBL] [Abstract][Full Text] [Related]
29. Activation of RB tumor suppressor protein and growth suppression of small cell lung carcinoma cells by reintroduction of p16INK4A gene.
Sumitomo K; Shimizu E; Shinohara A; Yokota J; Sone S
Int J Oncol; 1999 Jun; 14(6):1075-80. PubMed ID: 10339660
[TBL] [Abstract][Full Text] [Related]
30. Contribution of the dual coding capacity of the p16INK4a/MTS1/CDKN2 locus to human malignancies.
Larsen CJ
Prog Cell Cycle Res; 1997; 3():109-24. PubMed ID: 9552410
[TBL] [Abstract][Full Text] [Related]
31. Alternative product of the p16/CKDN2A locus connects the Rb and p53 tumor suppressors.
James MC; Peters G
Prog Cell Cycle Res; 2000; 4():71-81. PubMed ID: 10740816
[TBL] [Abstract][Full Text] [Related]
32. The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer.
Gazzeri S; Della Valle V; Chaussade L; Brambilla C; Larsen CJ; Brambilla E
Cancer Res; 1998 Sep; 58(17):3926-31. PubMed ID: 9731504
[TBL] [Abstract][Full Text] [Related]
33. Mouse models in tumor suppression.
Ghebranious N; Donehower LA
Oncogene; 1998 Dec; 17(25):3385-400. PubMed ID: 9917000
[TBL] [Abstract][Full Text] [Related]
34. The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway.
Martinelli P; Bonetti P; Sironi C; Pruneri G; Fumagalli C; Raviele PR; Volorio S; Pileri S; Chiarle R; McDuff FK; Tusi BK; Turner SD; Inghirami G; Pelicci PG; Colombo E
Blood; 2011 Jun; 117(24):6617-26. PubMed ID: 21518927
[TBL] [Abstract][Full Text] [Related]
35. [Clearing up the p16INK4a-p14/p19ARF imbroglio?].
Larsen CJ
Bull Cancer; 2001 Nov; 88(11):1055-8. PubMed ID: 11741798
[TBL] [Abstract][Full Text] [Related]
36. Parsing Ink4a/Arf: "pure" p16-null mice.
Sherr CJ
Cell; 2001 Sep; 106(5):531-4. PubMed ID: 11551500
[No Abstract] [Full Text] [Related]
37. Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4.
Byeon IJ; Li J; Ericson K; Selby TL; Tevelev A; Kim HJ; O'Maille P; Tsai MD
Mol Cell; 1998 Feb; 1(3):421-31. PubMed ID: 9660926
[TBL] [Abstract][Full Text] [Related]
38. [Regulation of hematopoietic stem cell self-renewal by aging-related genes].
Hirao A
Rinsho Ketsueki; 2006 May; 47(5):379-82. PubMed ID: 16784094
[No Abstract] [Full Text] [Related]
39. p16INK4a: a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression.
Larsen CJ
Oncogene; 1996 May; 12(10):2041-4. PubMed ID: 8668328
[No Abstract] [Full Text] [Related]
40. Replicative senescence revisited.
Marcotte R; Wang E
J Gerontol A Biol Sci Med Sci; 2002 Jul; 57(7):B257-69. PubMed ID: 12084796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
